© Copyright 2026 American Medical Association. All rights reserved.
Diphtheria toxoid is a vaccine designed to provide long-lasting immunity against diphtheria, a serious bacterial infection. The vaccine works by stimulating the body's immune system to produce antibodies that specifically target and neutralize the toxins produced by the diphtheria bacteria. The process of creating the toxoid involves culturing the bacteria in a controlled liquid medium, followed by purification and inactivation of the toxic substance they produce. This results in a non-live vaccine that is safe for administration. Due to the nature of toxoid vaccines, which do not contain live pathogens, it is essential to administer booster doses periodically to maintain immunity, as the protective effects can diminish over time. The CPT® Code 90719 specifically refers to the diphtheria toxoid vaccine administered via intramuscular injection, and it is important to note that this code solely represents the product used, rather than the administration process or any associated services.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.